FDA okays Celgene's Abraxane for pancreatic cancer

(Reuters) - U.S. regulators on Friday approved use of Celgene Corp's Abraxane to treat patients with pancreatic cancer that has spread to other parts of the body, citing a trial that showed the drug significantly prolonged survival.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news